BioStock Investor Meeting: OssDsign presents

22 September, 2022

OssDsign_AndersSvensson_BioStockInvestorMeeting — CEO Anders Svensson presenterar OssDsign

BioStock Investor Meeting: OssDsign presents

22 September, 2022

Medtech company OssDsign develops and manufactures regenerative implants and patient-specific solutions for the treatment of bone defects. CFO Anders Svensson attended the BioStock Investor Meeting where he talked about how sales in Japan have taken off and the company’s plans for the US market.

See OssDsign’s presentation below.

The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.